93 related articles for article (PubMed ID: 34347554)
1. Five
Wang Y; Yang Z; Chang X; Li J; Han Z
Int J Biol Markers; 2021 Jun; 36(2):17246008211033874. PubMed ID: 34347554
[TBL] [Abstract][Full Text] [Related]
2. The Correlation of Mouse Double Minute 4 (MDM4) Polymorphisms (rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576) with Cancer Susceptibility: A Meta-Analysis.
Chen J; Li X; Liu R; Xie Y; Liu Z; Xiong H; Li Y
Med Sci Monit; 2022 Mar; 28():e935671. PubMed ID: 35347102
[TBL] [Abstract][Full Text] [Related]
3. The associations between MDM4 gene polymorphisms and cancer risk.
Wang MJ; Luo YJ; Shi ZY; Xu XL; Yao GL; Liu RP; Zhao H
Oncotarget; 2016 Aug; 7(34):55611-55623. PubMed ID: 27742919
[TBL] [Abstract][Full Text] [Related]
4. A PRISMA-compliant meta-analysis of MDM4 genetic variants and cancer susceptibility.
Zhai Y; Dai Z; He H; Gao F; Yang L; Dong Y; Lu J
Oncotarget; 2016 Nov; 7(45):73935-73944. PubMed ID: 27738340
[TBL] [Abstract][Full Text] [Related]
5. Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
Hashemi M; Sanaei S; Hashemi SM; Eskandari E; Bahari G
Clin Breast Cancer; 2018 Oct; 18(5):e883-e891. PubMed ID: 29439926
[TBL] [Abstract][Full Text] [Related]
6. Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma.
Zhou L; Zhang X; Li Z; Zhou C; Li M; Tang X; Lu C; Li H; Yuan Q; Yang M
PLoS One; 2013; 8(5):e64331. PubMed ID: 23724042
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Association between MDM4 rs4245739 Single Nucleotide Polymorphism and Breast Cancer Susceptibility.
Pedram N; Pouladi N; Feizi MA; Montazeri V; Sakhinia E; Estiar MA
Clin Lab; 2016 Jul; 62(7):1303-1308. PubMed ID: 28164646
[TBL] [Abstract][Full Text] [Related]
8. The effect of LTA gene polymorphisms on cancer risk: an updated systematic review and meta- analysis.
Li J; Wang Y; Chang X; Han Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32420584
[TBL] [Abstract][Full Text] [Related]
9. Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility.
Liu J; Tang X; Li M; Lu C; Shi J; Zhou L; Yuan Q; Yang M
Breast Cancer Res Treat; 2013 Jul; 140(1):151-7. PubMed ID: 23793604
[TBL] [Abstract][Full Text] [Related]
10. MDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjects.
Xu C; Zhu J; Fu W; Liang Z; Song S; Zhao Y; Lyu L; Zhang A; He J; Duan P
Oncotarget; 2016 Nov; 7(44):71718-71726. PubMed ID: 27687591
[TBL] [Abstract][Full Text] [Related]
11. MDM4 polymorphisms associated with the risk but not the prognosis of esophageal cancer in Cixian high-incidence region from northern China.
Zhou R; Li Y; Wang N; Niu C; Huang X; Cao S; Huo X
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e435-e441. PubMed ID: 35098683
[TBL] [Abstract][Full Text] [Related]
12. MDM4 genetic variants and risk of gastric cancer in an Eastern Chinese population.
Wang MY; Jia M; He J; Zhou F; Qiu LX; Sun MH; Yang YJ; Wang JC; Jin L; Wang YN; Wei QY
Oncotarget; 2017 Mar; 8(12):19547-19555. PubMed ID: 28099948
[TBL] [Abstract][Full Text] [Related]
13. Association of rs11801299 and rs1380576 polymorphisms at MDM4 with risk, clinicopathological features and prognosis in patients with retinoblastoma.
Yu F; Jiang Z; Song A
Cancer Epidemiol; 2019 Feb; 58():153-159. PubMed ID: 30597480
[TBL] [Abstract][Full Text] [Related]
14. A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer.
Stegeman S; Moya L; Selth LA; Spurdle AB; Clements JA; Batra J
Endocr Relat Cancer; 2015 Apr; 22(2):265-76. PubMed ID: 25670033
[TBL] [Abstract][Full Text] [Related]
15. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
[TBL] [Abstract][Full Text] [Related]
16. A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.
Zhang Y; Sturgis EM; Wei P; Liu H; Wang Z; Ma Y; Liu C; Gu KJ; Wei Q; Li G
Mol Carcinog; 2019 Dec; 58(12):2276-2285. PubMed ID: 31513313
[TBL] [Abstract][Full Text] [Related]
17.
Chang X; Yang Z; Wang H; Wang Y; Li J; Zhang Y; Teng Z; Han Z
Nucleosides Nucleotides Nucleic Acids; 2022; 41(11):1205-1223. PubMed ID: 35797106
[TBL] [Abstract][Full Text] [Related]
18. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx.
Lu Z; Sturgis EM; Zhu L; Zhang H; Tao Y; Wei P; Wei Q; Li G
Mol Carcinog; 2018 Mar; 57(3):361-369. PubMed ID: 29073727
[TBL] [Abstract][Full Text] [Related]
19. MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk.
Gansmo LB; Romundstad P; Birkeland E; Hveem K; Vatten L; Knappskog S; Lønning PE
Cancer Med; 2015 Dec; 4(12):1901-7. PubMed ID: 26471763
[TBL] [Abstract][Full Text] [Related]
20. A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.
Gao F; Xiong X; Pan W; Yang X; Zhou C; Yuan Q; Zhou L; Yang M
PLoS One; 2015; 10(8):e0135647. PubMed ID: 26274820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]